Cite
An 19F magnetic resonance-based in vivo assay of solid tumor methotrexate resistance: proof of principle
MLA
William G. Bornmann, et al. “An 19F Magnetic Resonance-Based in Vivo Assay of Solid Tumor Methotrexate Resistance: Proof of Principle.” Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, vol. 11, no. 4, Mar. 2005. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....2b0afeb616008ff444c2464c54ed43ab&authtype=sso&custid=ns315887.
APA
William G. Bornmann, William M. Spees, Terence P. Gade, Jason A. Koutcher, Guangli Yang, Richard Gorlick, & William P. Tong. (2005). An 19F magnetic resonance-based in vivo assay of solid tumor methotrexate resistance: proof of principle. Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, 11(4).
Chicago
William G. Bornmann, William M. Spees, Terence P. Gade, Jason A. Koutcher, Guangli Yang, Richard Gorlick, and William P. Tong. 2005. “An 19F Magnetic Resonance-Based in Vivo Assay of Solid Tumor Methotrexate Resistance: Proof of Principle.” Clinical Cancer Research : An Official Journal of the American Association for Cancer Research 11 (4). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....2b0afeb616008ff444c2464c54ed43ab&authtype=sso&custid=ns315887.